{"id":"W2339999281","doi":"10.3899/jrheum.150641","title":"New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol","year":2015,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Tumor necrosis factor alpha; Arthritis; Oncology; Immunology; Internal medicine; Adalimumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002818384,0.0006912196,0.004154928,0.0004881868,0.0001197321,0.00002098355,0.0005983716,0.0004982568,0.0004116793],"category_scores_gemma":[0.00006650567,0.0004008899,0.001330023,0.00020499,0.0001431457,0.00008048078,0.00005478323,0.0002804334,0.00003349126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004703454,"about_ca_system_score_gemma":0.001465126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002979745,"about_ca_topic_score_gemma":0.0002601691,"domain_scores_codex":[0.995886,0.0005832191,0.00242819,0.0003720356,0.0001194623,0.0006111059],"domain_scores_gemma":[0.9957538,0.00115615,0.002416994,0.0004779887,0.0001112413,0.00008383311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004017618,0.0007641349,0.0003692652,0.001171464,0.004143365,0.00006017089,0.001249952,8.629296e-7,0.000002805474,0.0003654062,0.005585562,0.9858853],"study_design_scores_gemma":[0.009781876,0.002410011,0.00002403287,0.002046139,0.002842699,0.006373071,0.0004196458,0.000001018974,0.0001876346,0.0002089295,0.9753664,0.0003385407],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006194493,0.992889,0.0001581155,0.0004975668,0.002903374,0.001938495,0.0009753906,0.000009795594,0.000008790679],"genre_scores_gemma":[0.001997693,0.9960886,0.0008261133,0.000003849944,0.000071714,0.0003322195,0.0003687388,0.00005632872,0.0002547968],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9855467,"threshold_uncertainty_score":0.9998443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09187653286900763,"score_gpt":0.3158525180542813,"score_spread":0.2239759851852737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}